Richards, J. BrentWaterworth, DawnO'Rahilly, StephenHivert, Marie-FranceLoos, Ruth J. F.Perry, John R. B.Tanaka, ToshikoTimpson, Nicholas JohnSemple, Robert K.Soranzo, NicoleSong, KijoungRocha, NunoGrundberg, ElinDupuis, JoséeFlorez, Jose C.Langenberg, ClaudiaProkopenko, IngaSaxena, RichaSladek, RobertAulchenko, YuriiEvans, DavidWaeber, GerardErdmann, JeanetteBurnett, Mary-SusanSattar, NaveedDevaney, JosephWillenborg, ChristinaHingorani, AroonWitteman, Jaquelin C. M.Vollenweider, PeterGlaser, BeateHengstenberg, ChristianFerrucci, LuigiMelzer, DavidStark, KlausDeanfield, JohnWinogradow, JaninaGrassl, MartinaHall, Alistair S.Egan, Josephine M.Thompson, John R.Ricketts, Sally L.König, Inke R.Reinhard, WibkeGrundy, ScottWichmann, H-ErichBarter, PhilMahley, RobertKesaniemi, Y. AnteroRader, Daniel J.Reilly, Muredach P.Epstein, Stephen E.Stewart, Alexandre F. R.Van Duijn, Cornelia M.Schunkert, HeribertBurling, KeithDeloukas, PanosPastinen, TomiSamani, Nilesh J.McPherson, RuthDavey Smith, GeorgeFrayling, Timothy M.Wareham, Nicholas J.Meigs, James B.Mooser, VincentSpector, Tim D.2012-01-112012-01-112009-12-11Richards, J. Brent, Dawn Waterworth, Stephen O'Rahilly, Marie-France Hivert, Ruth J. F. Loos, John R. B. Perry, Toshiko Tanaka, Nicholas John Timpson, Robert K. Semple, Nicole Soranzo, Kijoung Song, Nuno Rocha, Elin Grundberg, Josée Dupuis, Jose C. Florez, Claudia Langenberg, Inga Prokopenko, Richa Saxena, Robert Sladek, Yurii Aulchenko, David Evans, Gerard Waeber, Jeanette Erdmann, Mary-Susan Burnett, Naveed Sattar, Joseph Devaney, Christina Willenborg, Aroon Hingorani, Jaquelin C. M. Witteman, Peter Vollenweider, Beate Glaser, Christian Hengstenberg, Luigi Ferrucci, David Melzer, Klaus Stark, John Deanfield, Janina Winogradow, Martina Grassl, Alistair S. Hall, Josephine M. Egan, John R. Thompson, Sally L. Ricketts, Inke R. König, Wibke Reinhard, Scott Grundy, H-Erich Wichmann, Phil Barter, Robert Mahley, Y. Antero Kesaniemi, Daniel J. Rader, Muredach P. Reilly, Stephen E. Epstein, Alexandre F. R. Stewart, Cornelia M. Van Duijn, Heribert Schunkert, Keith Burling, Panos Deloukas, Tomi Pastinen, Nilesh J. Samani, Ruth McPherson, George Davey Smith, Timothy M. Frayling, Nicholas J. Wareham, James B. Meigs, Vincent Mooser, Tim D. Spector. "A Genome-Wide Association Study Reveals Variants in ARL15 that Influence Adiponectin Levels" PLoS Genetics 5(12):e1000768. (2009)1553-7404https://hdl.handle.net/2144/3099The adipocyte-derived protein adiponectin is highly heritable and inversely associated with risk of type 2 diabetes mellitus (T2D) and coronary heart disease (CHD). We meta-analyzed 3 genome-wide association studies for circulating adiponectin levels (n = 8,531) and sought validation of the lead single nucleotide polymorphisms (SNPs) in 5 additional cohorts (n = 6,202). Five SNPs were genome-wide significant in their relationship with adiponectin (P≤5×10−8). We then tested whether these 5 SNPs were associated with risk of T2D and CHD using a Bonferroni-corrected threshold of P≤0.011 to declare statistical significance for these disease associations. SNPs at the adiponectin-encoding ADIPOQ locus demonstrated the strongest associations with adiponectin levels (P-combined = 9.2×10−19 for lead SNP, rs266717, n = 14,733). A novel variant in the ARL15 (ADP-ribosylation factor-like 15) gene was associated with lower circulating levels of adiponectin (rs4311394-G, P-combined = 2.9×10−8, n = 14,733). This same risk allele at ARL15 was also associated with a higher risk of CHD (odds ratio [OR] = 1.12, P = 8.5×10−6, n = 22,421) more nominally, an increased risk of T2D (OR = 1.11, P = 3.2×10−3, n = 10,128), and several metabolic traits. Expression studies in humans indicated that ARL15 is well-expressed in skeletal muscle. These findings identify a novel protein, ARL15, which influences circulating adiponectin levels and may impact upon CHD risk. Author Summary Through a meta-analysis of genome-wide association studies of 14,733 individuals, we identified common base-pair variants in the genome which influence circulating adiponectin levels. Since adiponectin is an adipocyte-derived circulating protein which has been inversely associated with risk of obesity-related diseases such as type 2 diabetes (T2D) and coronary heart disease (CHD), we next sought to understand if the identified variants influencing adiponectin levels also influence risk of T2D, CHD, and several metabolic traits. In addition to confirming that variation at the ADIPOQ locus influences adiponectin levels, our analyses point to a variant in the ARL15 (ADP-ribosylation factor-like 15) locus which decreases adiponectin levels and increases risk of CHD and T2D. Further, this same variant was associated with increased fasting insulin levels and glycated hemoglobin. While the function of ARL15 is not known, we provide insight into the tissue specificity of ARL15 expression. These results thus provide novel insights into the physiology of the adiponectin pathway and obesity-related diseases.enRichards et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Article10.1371/journal.pgen.1000768200111042781107